| Literature DB >> 32583371 |
Mustafa Soytas1, Mustafa Yucel Boz2, Vahit Guzelburc2, Gokhan Calik2, Mehmet Cagri Kactan2, Rahim Horuz2, Ziya Akbulut2, Selami Albayrak2.
Abstract
PURPOSE: It is reported that surgical procedures performed during the COVID-19 pandemic are accompanied by high complications and risks. In this study, the urological interventions applied with appropriate infrastructure and protocols during the pandemic in the pandemic hospital that is carrying out the COVID-19 struggle are analyzed.Entities:
Keywords: COVID-19; Coronavirus; Elective case; Emergency case; Priority case; SARS-CoV-2; Urology
Mesh:
Year: 2020 PMID: 32583371 PMCID: PMC7312099 DOI: 10.1007/s11255-020-02553-4
Source DB: PubMed Journal: Int Urol Nephrol ISSN: 0301-1623 Impact factor: 2.370
Fig. 1COVID-19 patient evaluation and approach algorithm
Demographics and comorbidities
| Total ( | No./% | |
|---|---|---|
| Age, mean, year ± std | 47 ± 14.7 | |
| Sex | ||
| Male | 45/69.2% | |
| Female | 20/30.8% | |
| Comorbidity | ||
| Malignancy | 14/21.5% | |
| Chronic kidney disease (CKD) | 7/10.7% | |
| Hypertension | 5/7.6% | |
| Diabetes | 4/6.1% | |
| Cardiovascular disease | 4/6.1% | |
| Chronic obstructive pulmonary disease | 2/3.1% | |
| Cerebrospinal disease | 1/1.6% |
Surgical, non-surgical interventions and COVID-19 follow-up
| Emergency | High priority | Intermediate priority | Low priority | Total | COVID-19 testing in 7–14 days follow-up | |
|---|---|---|---|---|---|---|
| Surgeries | ||||||
| Radical nephrectomy | ||||||
| Open | 2 | 2 | 4 | Negative | ||
| Laparoscopic | 1 | 1 | Negative | |||
| Radical cystectomy + IC | 1 | 1 | Negative | |||
| Robotic radical prostatectomy | 1 | 1 | Negative | |||
| Radical orchiectomy | 1 | 1 | Negative | |||
| TUR-bladder | 1 | 10 | 11 | Negative | ||
| TRUS prostate biopsy | 2 | 2 | Negative | |||
| Transvesical prostatectomy | 1 | 1 | Negative | |||
| RIRS | 1 | 8 | 9 | Negative | ||
| Ureterorenoscopy | 7 | 4 | 4 | 15 | Negative | |
| Double-J removal | 6 | 6 | Negative | |||
| Double-J stenting | 4 | 4 | Negative | |||
| Testicular exploration | 1 | 1 | Negative | |||
| Nephrostomy insertion | 4 | 4 | Negative | |||
| Internal urethrotomy | 1 | 1 | Negative | |||
| Botox application | 1 | 1 | Negative | |||
| Penile fracture repair | 1 | 1 | Negative | |||
| Sacral neuromodulation | 1 | 1 | Negative | |||
| Total | 18 | 15 | 4 | 28 | 65 | |
| Non-surgical procedures | ||||||
| Urodynamics | 3 | 3 | Negative | |||
| Uroflowmetry | 64 | 64 | Negative | |||
| Urethral catheterization | 20 | 20 | Negative | |||
| ESWL | 4 | 4 | Negative | |||
| BCG-session | 4 | 4 | Negative | |||
| Total | 20 | 75 | 95 | |||
IC ileal conduit, RIRS retrograde intrarenal surgery, TUR transurethral resection, TRUS transrectal ultrasonography, ESWL extracorporeal shock wave lithotripsy, BCG Bacillus Calmette–Guérin
Fig. 2Patient and procedure distribution in COVID-19 pandemic by weeks